Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raed Alroughani

Showing results (31-40 of 223) with videos related to

Pageof 23
Sort By:
Multiple Sclerosis and Related Disorders|February 8, 2018
A longitudinal study of JC virus serostatus stability among multiple sclerosis patientsRaed Alroughani, Saeed Akhtar, Samar Ahmed, et al.
The Journal of Headache and Pain|October 15, 2017
Burden of migraine in a Kuwaiti population: a door-to-door surveyJasem Yousef Al-Hashel, Samar Farouk Ahmed, Raed Alroughani
Neurology and Therapy|August 7, 2017
Effectiveness and Safety of Dimethyl Fumarate Treatment in Relapsing Multiple Sclerosis Patients: Real-World EvidenceRaed Alroughani, Samar Farouk Ahmed, Raed Behbehani, et al.
Clinical Neurology and Neurosurgery|September 12, 2020
Impact of coronavirus disease (COVID-19) pandemic on multiple sclerosis careSara Salama, Samar Farouk Ahmed, Ismail Ibrahim Ismail, et al.
Journal of Neuroimmunology|March 13, 2017
Assessment of plasma biomarkers for their association with Multiple Sclerosis progressionSindhu Jacob, Asmaa Al-Kandari, Raed Alroughani, et al.
Springerplus|February 4, 2015
Status migrainosus as an initial presentation of multiple sclerosisRaed Alroughani, Samar F Ahmed, Riyadh Khan, et al.
CNS Drugs|July 12, 2014
Real-world use of fingolimod in patients with relapsing remitting multiple sclerosis: a retrospective study using the national multiple sclerosis registry in KuwaitJasem Al-Hashel, Samar F Ahmed, Raed Behbehani, et al.
Journal of Neuroimmunology|February 21, 2019
Angiopoietin-like proteins in multiple sclerosisRabeah Al-Temaimi, Preethi Cherian, Mohamed Abu-Farha, et al.
Multiple Sclerosis and Related Disorders|May 28, 2025
Ocrelizumab for pediatric relapsing multiple sclerosisRaed Alroughani, Malak AlMojel, Jasem Al-Hashel, et al.
Pediatric Neurology|April 9, 2017
The Use of Natalizumab in Pediatric Patients With Active Relapsing Multiple Sclerosis: A Prospective StudyRaed Alroughani, Samar Farouk Ahmed, Raed Behbehani, et al.
Pageof 23

Showing results (31-40 of 223) with videos related to

Sort By:
Pageof 23
Multiple Sclerosis and Related Disorders|February 8, 2018
A longitudinal study of JC virus serostatus stability among multiple sclerosis patientsRaed Alroughani, Saeed Akhtar, Samar Ahmed, et al.
The Journal of Headache and Pain|October 15, 2017
Burden of migraine in a Kuwaiti population: a door-to-door surveyJasem Yousef Al-Hashel, Samar Farouk Ahmed, Raed Alroughani
Neurology and Therapy|August 7, 2017
Effectiveness and Safety of Dimethyl Fumarate Treatment in Relapsing Multiple Sclerosis Patients: Real-World EvidenceRaed Alroughani, Samar Farouk Ahmed, Raed Behbehani, et al.
Clinical Neurology and Neurosurgery|September 12, 2020
Impact of coronavirus disease (COVID-19) pandemic on multiple sclerosis careSara Salama, Samar Farouk Ahmed, Ismail Ibrahim Ismail, et al.
Journal of Neuroimmunology|March 13, 2017
Assessment of plasma biomarkers for their association with Multiple Sclerosis progressionSindhu Jacob, Asmaa Al-Kandari, Raed Alroughani, et al.
Springerplus|February 4, 2015
Status migrainosus as an initial presentation of multiple sclerosisRaed Alroughani, Samar F Ahmed, Riyadh Khan, et al.
CNS Drugs|July 12, 2014
Real-world use of fingolimod in patients with relapsing remitting multiple sclerosis: a retrospective study using the national multiple sclerosis registry in KuwaitJasem Al-Hashel, Samar F Ahmed, Raed Behbehani, et al.
Journal of Neuroimmunology|February 21, 2019
Angiopoietin-like proteins in multiple sclerosisRabeah Al-Temaimi, Preethi Cherian, Mohamed Abu-Farha, et al.
Multiple Sclerosis and Related Disorders|May 28, 2025
Ocrelizumab for pediatric relapsing multiple sclerosisRaed Alroughani, Malak AlMojel, Jasem Al-Hashel, et al.
Pediatric Neurology|April 9, 2017
The Use of Natalizumab in Pediatric Patients With Active Relapsing Multiple Sclerosis: A Prospective StudyRaed Alroughani, Samar Farouk Ahmed, Raed Behbehani, et al.
Pageof 23